Code intelligence

LCD-L39658 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance referencing code LCD-L39658.

Elevated code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Elevated

Critical

High

100%

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L39658: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — CGS

Policy LCD-L39658 · Pulmonology

High

The final LCD L39658 addresses the use of molecular biomarkers for risk stratification of indeterminate pulmonary nodules following bronchoscopy, effective from June 18, 2026. Healthcare providers in

View alert